CN Patent

CN102127087B — 喹唑啉衍生物

Assigned to Jiangsu Simcere Pharmaceutical Co Ltd · Expires 2012-07-04 · 14y expired

What this patent protects

本发明涉及通式为(Ⅰ)喹唑啉衍生物或其可药用盐，式中R、Q如正文所述；其制备方法以及含有效剂量的通式(Ⅰ)化合物或其可药用盐组合物。通式为(Ⅰ)的化合物或其药用盐可以用于治疗如癌症等细胞增生类疾病以及与激酶相关的其他病症。

USPTO Abstract

本发明涉及通式为(Ⅰ)喹唑啉衍生物或其可药用盐，式中R、Q如正文所述；其制备方法以及含有效剂量的通式(Ⅰ)化合物或其可药用盐组合物。通式为(Ⅰ)的化合物或其药用盐可以用于治疗如癌症等细胞增生类疾病以及与激酶相关的其他病症。

Drugs covered by this patent

Patent Metadata

Patent number
CN102127087B
Jurisdiction
CN
Classification
—
Expires
2012-07-04
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Simcere Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.